BLU Products, Inc.; Analysis to Aid Public Comment, 19762-19764 [2018-09545]
Download as PDF
19762
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
nonbank subsidiary, Masonry Capital
Management, LLC, Charlottesville,
Virginia in financial and investment
advisory activities and private
placement services pursuant to section
225.28(b)(6)(i) and 225.28(b)(7)(iii) of
Regulation Y.
Board of Governors of the Federal Reserve
System, May 1, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018–09517 Filed 5–3–18; 8:45 am]
BILLING CODE P
FEDERAL TRADE COMMISSION
[File No. 172 3025]
BLU Products, Inc.; Analysis to Aid
Public Comment
Federal Trade Commission.
Proposed Consent Agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair or
deceptive acts or practices. The attached
Analysis to Aid Public Comment
describes both the allegations in the
complaint and the terms of the consent
order—embodied in the consent
agreement—that would settle these
allegations.
SUMMARY:
Comments must be received on
or before May 30, 2018.
ADDRESSES: Interested parties may file a
comment online or on paper, by
following the instructions in the
Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write: ‘‘BLU Products, Inc.’’ on
your comment, and file your comment
online at https://
ftcpublic.commentworks.com/ftc/
bluproductsconsent by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, write ‘‘BLU Products, Inc.’’ on
your comment and on the envelope, and
mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW, Suite CC–
5610 (Annex D), Washington, DC 20580;
or deliver your comment to: Federal
Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610 (Annex
D), Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT: JahJuin Ho (202–326–3463) and Ryan
Mehm (202–326–2918), Bureau of
Consumer Protection, 600 Pennsylvania
Avenue NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 6(f) of the Federal Trade
amozie on DSK3GDR082PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
Commission Act, 15 U.S.C. 46(f), and
FTC Rule 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing a consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of thirty (30) days. The following
Analysis to Aid Public Comment
describes the terms of the consent
agreement, and the allegations in the
complaint. An electronic copy of the
full text of the consent agreement
package can be obtained from the FTC
Home Page (for April 30, 2018), on the
World Wide Web, at https://
www.ftc.gov/news-events/commissionactions.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before May 30, 2018. Write ‘‘BLU
Products, Inc.’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission website, at https://
www.ftc.gov/policy/public-comments.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
bluproductsconsent by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that
website.
If you prefer to file your comment on
paper, write ‘‘BLU Products, Inc.’’ on
your comment and on the envelope, and
mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW, Suite CC–
5610 (Annex D), Washington, DC 20580;
or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610 (Annex D),
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible FTC website
at https://www.ftc.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted on the public FTC
website—as legally required by FTC
Rule 4.9(b)—we cannot redact or
remove your comment from the FTC
website, unless you submit a
confidentiality request that meets the
requirements for such treatment under
FTC Rule 4.9(c), and the General
Counsel grants that request.
Visit the FTC website at https://
www.ftc.gov to read this Notice and the
news release describing it. The FTC Act
and other laws that the Commission
administers permit the collection of
public comments to consider and use in
this proceeding, as appropriate. The
Commission will consider all timely
and responsive public comments that it
receives on or before May 30, 2018. For
information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
Analysis of Proposed Consent Order to
Aid Public Comment
The Federal Trade Commission
(‘‘Commission’’) has accepted, subject to
E:\FR\FM\04MYN1.SGM
04MYN1
amozie on DSK3GDR082PROD with NOTICES
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
final approval, an agreement containing
a consent order from BLU Products, Inc.
(‘‘BLU’’) and individual Respondent
Samuel Ohev-Zion (collectively,
‘‘Respondents’’).
The proposed consent order
(‘‘proposed order’’) has been placed on
the public record for thirty (30) days for
receipt of comments by interested
persons. Comments received during this
period will become part of the public
record. After thirty (30) days, the
Commission again will review the
agreement and the comments received,
and will decide whether it should
withdraw from the agreement or make
final the agreement’s proposed order.
BLU is a mobile device manufacturer
that sells smartphone and other mobile
devices to consumers through retailers
such as Amazon, Walmart, and Best
Buy. Samuel Ohev-Zion is an owner and
the President and CEO of BLU.
Individually or in concert with others,
Mr. Ohev-Zion controlled or had
authority to control, or participated in
the acts and practices alleged in the
proposed complaint.
Respondents purchase the
smartphones they sell to consumers
from Original Device Manufacturers
(‘‘ODMs’’). ODMs manufacture and
customize mobile devices branded with
the BLU name based on instructions
provided by Respondents. As part of
this process, since at least 2015, in order
to provide firmware updating services,
BLU has licensed software from ADUPS
Technology Co., LTD (‘‘ADUPS’’) and
directed ODMs to preinstall this
software on Respondents’ mobile
devices.
ADUPS is a China-based company
that offers advertising, data mining, and
firmware over-the-air (‘‘FOTA’’) update
services to mobile and Internet of
Things connected devices. FOTA
updates allow device manufacturers to
issue security patches or operating
system upgrades to devices over
wireless and cellular networks.
Until at least November 2016 the
ADUPS software on BLU devices
transmitted personal information about
consumers to ADUPS’ servers without
consumers’ knowledge and consent,
including the full contents of text
messages, real-time cellular tower
location data, call and text message logs
with full telephone numbers, contact
lists, and a list of applications used and
installed on each device. ADUPS
software collected and transmitted
consumers’ text messages to its servers
every 72 hours. ADUPS software also
collected consumers’ location data in
real-time and transmitted this data back
to its servers every 24 hours.
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
The Commission’s proposed twocount complaint alleges that
Respondents violated Section 5(a) of the
Federal Trade Commission Act. The
first count alleges that Respondents
deceived consumers about BLU’s data
collection and sharing practices by
falsely representing in BLU’s privacy
policy that they limit the disclosure of
users’ information to third-party service
providers only to the extent necessary to
perform their services or functions on
behalf of BLU and not for other
purposes. Contrary to the privacy
policy, personal information from BLU
devices sold by Respondents was
transmitted to ADUPS that was not
needed to perform its services or
functions on behalf of BLU, including
FOTA updates.
The second count alleges that
Respondents deceived consumers about
BLU’s data security practices by falsely
representing that they implemented
appropriate physical, electronic, and
managerial security procedures to
protect the personal information
provided by consumers. The proposed
complaint alleges that Respondents did
not implement appropriate physical,
electronic and managerial security
procedures. For example, the proposed
complaint alleges that Respondents
failed to implement appropriate security
procedures to oversee the security
practices of their service providers, such
as by: (1) Failing to perform adequate
due diligence in the selection and
retention of service providers; (2) failing
to adopt and implement written data
security standards, policies, procedures
or practices that apply to the oversight
of their service providers; (3) failing to
contractually require their service
providers to adopt and implement data
security standards, policies, procedures
or practices; and (4) failing to
adequately assess the privacy and
security risks of third-party software,
such as ADUPS.
The proposed order contains
provisions designed to prevent
Respondents from engaging in the same
or similar acts or practices in the future.
Part I of the proposed order prohibits
Respondents from misrepresenting: (1)
The extent to which they collect, use,
share, or disclose any personal
information; (2) the extent to which
consumers may exercise control over
the collection, use, or disclosure of
personal information; and (3) the extent
to which the implement physical,
electronic, and managerial security
procedures to protect personal
information.
Part II of the proposed order requires
Respondents to establish and
implement, and thereafter maintain, a
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
19763
comprehensive security program that is
reasonably designed to: (1) Address
security risks related to the
development and management of new
and existing covered devices, and (2)
protect the security, confidentiality, and
integrity of personal information. The
program must be fully documented in
writing and must contain
administrative, technical, and physical
safeguards appropriate to Respondents’
size and complexity, the nature and
scope of Respondents’ activities, and the
sensitivity of the covered device’s
function or the personal information.
Part III of the proposed order requires
Respondents to obtain an assessment
and report from a qualified, objective,
independent third-party professional
covering the first one hundred eighty
(180) days after issuance of the order
and each 2-year period thereafter for 20
years after issuance of the order. Each
assessment must, among other things:
(1) Set forth the administrative,
technical, and physical safeguards that
Respondents have implemented during
the reporting period; (2) explain how
such safeguards are appropriate to
Respondents’ size and complexity, the
nature and scope of Respondents’
activities, and the sensitivity of the
covered device’s function or the
personal information; (3) explain how
the safeguards implemented meet or
exceed the protections required by Part
II of the proposed order; and (4) certify
that Respondents’ security program is
operating with sufficient effectiveness to
provide reasonable assurance that the
security of covered devices and the
privacy, security, confidentiality, and
integrity of personal information is
protected.
Part IV of the proposed order requires
Respondents, prior to collecting or
disclosing any covered information, to:
(A) Clearly and conspicuously disclose
to the consumer, separate and apart
from ‘‘privacy policy,’’ ‘‘terms of use’’
page, or similar document, (1) the
categories of covered information that
Respondents collect, use, or share, (2)
the identity of any third parties that
receive any covered information, and (3)
all purposes for Respondents’
collection, use, or sharing of covered
information; and (B) obtain the
consumer’s affirmative express consent.
Parts V through IX of the proposed
order are reporting and compliance
provisions. Part V requires
acknowledgment of the order and
dissemination of the order now and in
the future to persons with supervisory
responsibilities and all employees,
agents, and representatives who
participate in conducted relating to the
subject matter of the order. Part VI
E:\FR\FM\04MYN1.SGM
04MYN1
19764
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
ensures notification to the FTC of
changes in corporate status and
mandates that Respondents submit an
initial compliance report to the FTC.
Part VII requires Respondents to retain
documents relating to its compliance
with the order for a five (5) year period.
Part VIII mandates that Respondents
make available to the FTC information
or subsequent compliance reports, as
requested. Part IX is a provision
‘‘sunsetting’’ the order after twenty (20)
years, with certain exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the complaint
or proposed order, or to modify in any
way the proposed order’s terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2018–09545 Filed 5–3–18; 8:45 am]
BILLING CODE 6750–01–P
FEDERAL TRADE COMMISSION
[File No. 181 0017]
Amneal Holdings, LLC, and Impax
Laboratories, Inc.; Analysis to Aid
Public Comment
Federal Trade Commission.
Proposed Consent Agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair methods
of competition. The attached Analysis to
Aid Public Comment describes both the
allegations in the complaint and the
terms of the consent order—embodied
in the consent agreement—that would
settle these allegations.
DATES: Comments must be received on
or before May 29, 2018.
ADDRESSES: Interested parties may file a
comment online or on paper, by
following the instructions in the
Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write: ‘‘In the Matter of Amneal
Holdings, LLC, and Impax Laboratories,
Inc.; File No. 181 0017’’ on your
comment, and file your comment online
at https://ftcpublic.commentworks.com/
ftc/amnealimpaxdivest by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, write ‘‘In the Matter of Amneal
Holdings, LLC, and Impax Laboratories,
Inc.; File No. 181 0017’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex D),
amozie on DSK3GDR082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610 (Annex
D), Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT: Kari
Wallace (202–326–3085), Bureau of
Competition, 600 Pennsylvania Avenue
NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 6(f) of the Federal Trade
Commission Act, 15 U.S.C. 46(f), and
FTC Rule 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing consent
orders to divest and providing for other
relief to resolve the allegations in the
complaint, having been filed with and
accepted, subject to final approval, by
the Commission, has been placed on the
public record for a period of thirty (30)
days. The following Analysis to Aid
Public Comment describes the terms of
the consent agreement, and the
allegations in the complaint. An
electronic copy of the full text of the
consent agreement package can be
obtained from the FTC Home Page (for
April 27, 2018), on the World Wide
Web, at https://www.ftc.gov/newsevents/commission-actions.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before May 29, 2018. Write ‘‘In the
Matter of Amneal Holdings, LLC, and
Impax Laboratories, Inc.; File No. 181
0017’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission website, at https://
www.ftc.gov/policy/public-comments.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
amnealimpaxdivest by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that
website.
If you prefer to file your comment on
paper, write ‘‘In the Matter of Amneal
Holdings, LLC, and Impax Laboratories,
Inc.; File No. 181 0017’’ on your
comment and on the envelope, and mail
your comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex D),
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610 (Annex
D), Washington, DC. 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible FTC website
at https://www.ftc.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted on the public FTC
website—as legally required by FTC
Rule 4.9(b)—we cannot redact or
remove your comment from the FTC
website, unless you submit a
confidentiality request that meets the
requirements for such treatment under
FTC Rule 4.9(c), and the General
Counsel grants that request.
Visit the FTC website at https://
www.ftc.gov to read this Notice and the
news release describing it. The FTC Act
E:\FR\FM\04MYN1.SGM
04MYN1
Agencies
[Federal Register Volume 83, Number 87 (Friday, May 4, 2018)]
[Notices]
[Pages 19762-19764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09545]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[File No. 172 3025]
BLU Products, Inc.; Analysis to Aid Public Comment
AGENCY: Federal Trade Commission.
ACTION: Proposed Consent Agreement.
-----------------------------------------------------------------------
SUMMARY: The consent agreement in this matter settles alleged
violations of federal law prohibiting unfair or deceptive acts or
practices. The attached Analysis to Aid Public Comment describes both
the allegations in the complaint and the terms of the consent order--
embodied in the consent agreement--that would settle these allegations.
DATES: Comments must be received on or before May 30, 2018.
ADDRESSES: Interested parties may file a comment online or on paper, by
following the instructions in the Request for Comment part of the
SUPPLEMENTARY INFORMATION section below. Write: ``BLU Products, Inc.''
on your comment, and file your comment online at https://ftcpublic.commentworks.com/ftc/bluproductsconsent by following the
instructions on the web-based form. If you prefer to file your comment
on paper, write ``BLU Products, Inc.'' on your comment and on the
envelope, and mail your comment to the following address: Federal Trade
Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite
CC-5610 (Annex D), Washington, DC 20580; or deliver your comment to:
Federal Trade Commission, Office of the Secretary, Constitution Center,
400 7th Street SW, 5th Floor, Suite 5610 (Annex D), Washington, DC
20024.
FOR FURTHER INFORMATION CONTACT: Jah-Juin Ho (202-326-3463) and Ryan
Mehm (202-326-2918), Bureau of Consumer Protection, 600 Pennsylvania
Avenue NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal
Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule 2.34, 16 CFR 2.34,
notice is hereby given that the above-captioned consent agreement
containing a consent order to cease and desist, having been filed with
and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of thirty (30) days. The
following Analysis to Aid Public Comment describes the terms of the
consent agreement, and the allegations in the complaint. An electronic
copy of the full text of the consent agreement package can be obtained
from the FTC Home Page (for April 30, 2018), on the World Wide Web, at
https://www.ftc.gov/news-events/commission-actions.
You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before May 30, 2018.
Write ``BLU Products, Inc.'' on your comment. Your comment--including
your name and your state--will be placed on the public record of this
proceeding, including, to the extent practicable, on the public
Commission website, at https://www.ftc.gov/policy/public-comments.
Postal mail addressed to the Commission is subject to delay due to
heightened security screening. As a result, we encourage you to submit
your comments online. To make sure that the Commission considers your
online comment, you must file it at https://ftcpublic.commentworks.com/ftc/bluproductsconsent by following the instructions on the web-based
form. If this Notice appears at https://www.regulations.gov/#!home, you
also may file a comment through that website.
If you prefer to file your comment on paper, write ``BLU Products,
Inc.'' on your comment and on the envelope, and mail your comment to
the following address: Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue NW, Suite CC-5610 (Annex D),
Washington, DC 20580; or deliver your comment to the following address:
Federal Trade Commission, Office of the Secretary, Constitution Center,
400 7th Street SW, 5th Floor, Suite 5610 (Annex D), Washington, DC
20024. If possible, submit your paper comment to the Commission by
courier or overnight service.
Because your comment will be placed on the publicly accessible FTC
website at https://www.ftc.gov, you are solely responsible for making
sure that your comment does not include any sensitive or confidential
information. In particular, your comment should not include any
sensitive personal information, such as your or anyone else's Social
Security number; date of birth; driver's license number or other state
identification number, or foreign country equivalent; passport number;
financial account number; or credit or debit card number. You are also
solely responsible for making sure that your comment does not include
any sensitive health information, such as medical records or other
individually identifiable health information. In addition, your comment
should not include any ``trade secret or any commercial or financial
information which . . . is privileged or confidential''--as provided by
Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2),
16 CFR 4.10(a)(2)--including in particular competitively sensitive
information such as costs, sales statistics, inventories, formulas,
patterns, devices, manufacturing processes, or customer names.
Comments containing material for which confidential treatment is
requested must be filed in paper form, must be clearly labeled
``Confidential,'' and must comply with FTC Rule 4.9(c). In particular,
the written request for confidential treatment that accompanies the
comment must include the factual and legal basis for the request, and
must identify the specific portions of the comment to be withheld from
the public record. See FTC Rule 4.9(c). Your comment will be kept
confidential only if the General Counsel grants your request in
accordance with the law and the public interest. Once your comment has
been posted on the public FTC website--as legally required by FTC Rule
4.9(b)--we cannot redact or remove your comment from the FTC website,
unless you submit a confidentiality request that meets the requirements
for such treatment under FTC Rule 4.9(c), and the General Counsel
grants that request.
Visit the FTC website at https://www.ftc.gov to read this Notice and
the news release describing it. The FTC Act and other laws that the
Commission administers permit the collection of public comments to
consider and use in this proceeding, as appropriate. The Commission
will consider all timely and responsive public comments that it
receives on or before May 30, 2018. For information on the Commission's
privacy policy, including routine uses permitted by the Privacy Act,
see https://www.ftc.gov/site-information/privacy-policy.
Analysis of Proposed Consent Order to Aid Public Comment
The Federal Trade Commission (``Commission'') has accepted, subject
to
[[Page 19763]]
final approval, an agreement containing a consent order from BLU
Products, Inc. (``BLU'') and individual Respondent Samuel Ohev-Zion
(collectively, ``Respondents'').
The proposed consent order (``proposed order'') has been placed on
the public record for thirty (30) days for receipt of comments by
interested persons. Comments received during this period will become
part of the public record. After thirty (30) days, the Commission again
will review the agreement and the comments received, and will decide
whether it should withdraw from the agreement or make final the
agreement's proposed order.
BLU is a mobile device manufacturer that sells smartphone and other
mobile devices to consumers through retailers such as Amazon, Walmart,
and Best Buy. Samuel Ohev-Zion is an owner and the President and CEO of
BLU. Individually or in concert with others, Mr. Ohev-Zion controlled
or had authority to control, or participated in the acts and practices
alleged in the proposed complaint.
Respondents purchase the smartphones they sell to consumers from
Original Device Manufacturers (``ODMs''). ODMs manufacture and
customize mobile devices branded with the BLU name based on
instructions provided by Respondents. As part of this process, since at
least 2015, in order to provide firmware updating services, BLU has
licensed software from ADUPS Technology Co., LTD (``ADUPS'') and
directed ODMs to preinstall this software on Respondents' mobile
devices.
ADUPS is a China-based company that offers advertising, data
mining, and firmware over-the-air (``FOTA'') update services to mobile
and Internet of Things connected devices. FOTA updates allow device
manufacturers to issue security patches or operating system upgrades to
devices over wireless and cellular networks.
Until at least November 2016 the ADUPS software on BLU devices
transmitted personal information about consumers to ADUPS' servers
without consumers' knowledge and consent, including the full contents
of text messages, real-time cellular tower location data, call and text
message logs with full telephone numbers, contact lists, and a list of
applications used and installed on each device. ADUPS software
collected and transmitted consumers' text messages to its servers every
72 hours. ADUPS software also collected consumers' location data in
real-time and transmitted this data back to its servers every 24 hours.
The Commission's proposed two-count complaint alleges that
Respondents violated Section 5(a) of the Federal Trade Commission Act.
The first count alleges that Respondents deceived consumers about BLU's
data collection and sharing practices by falsely representing in BLU's
privacy policy that they limit the disclosure of users' information to
third-party service providers only to the extent necessary to perform
their services or functions on behalf of BLU and not for other
purposes. Contrary to the privacy policy, personal information from BLU
devices sold by Respondents was transmitted to ADUPS that was not
needed to perform its services or functions on behalf of BLU, including
FOTA updates.
The second count alleges that Respondents deceived consumers about
BLU's data security practices by falsely representing that they
implemented appropriate physical, electronic, and managerial security
procedures to protect the personal information provided by consumers.
The proposed complaint alleges that Respondents did not implement
appropriate physical, electronic and managerial security procedures.
For example, the proposed complaint alleges that Respondents failed to
implement appropriate security procedures to oversee the security
practices of their service providers, such as by: (1) Failing to
perform adequate due diligence in the selection and retention of
service providers; (2) failing to adopt and implement written data
security standards, policies, procedures or practices that apply to the
oversight of their service providers; (3) failing to contractually
require their service providers to adopt and implement data security
standards, policies, procedures or practices; and (4) failing to
adequately assess the privacy and security risks of third-party
software, such as ADUPS.
The proposed order contains provisions designed to prevent
Respondents from engaging in the same or similar acts or practices in
the future.
Part I of the proposed order prohibits Respondents from
misrepresenting: (1) The extent to which they collect, use, share, or
disclose any personal information; (2) the extent to which consumers
may exercise control over the collection, use, or disclosure of
personal information; and (3) the extent to which the implement
physical, electronic, and managerial security procedures to protect
personal information.
Part II of the proposed order requires Respondents to establish and
implement, and thereafter maintain, a comprehensive security program
that is reasonably designed to: (1) Address security risks related to
the development and management of new and existing covered devices, and
(2) protect the security, confidentiality, and integrity of personal
information. The program must be fully documented in writing and must
contain administrative, technical, and physical safeguards appropriate
to Respondents' size and complexity, the nature and scope of
Respondents' activities, and the sensitivity of the covered device's
function or the personal information.
Part III of the proposed order requires Respondents to obtain an
assessment and report from a qualified, objective, independent third-
party professional covering the first one hundred eighty (180) days
after issuance of the order and each 2-year period thereafter for 20
years after issuance of the order. Each assessment must, among other
things: (1) Set forth the administrative, technical, and physical
safeguards that Respondents have implemented during the reporting
period; (2) explain how such safeguards are appropriate to Respondents'
size and complexity, the nature and scope of Respondents' activities,
and the sensitivity of the covered device's function or the personal
information; (3) explain how the safeguards implemented meet or exceed
the protections required by Part II of the proposed order; and (4)
certify that Respondents' security program is operating with sufficient
effectiveness to provide reasonable assurance that the security of
covered devices and the privacy, security, confidentiality, and
integrity of personal information is protected.
Part IV of the proposed order requires Respondents, prior to
collecting or disclosing any covered information, to: (A) Clearly and
conspicuously disclose to the consumer, separate and apart from
``privacy policy,'' ``terms of use'' page, or similar document, (1) the
categories of covered information that Respondents collect, use, or
share, (2) the identity of any third parties that receive any covered
information, and (3) all purposes for Respondents' collection, use, or
sharing of covered information; and (B) obtain the consumer's
affirmative express consent.
Parts V through IX of the proposed order are reporting and
compliance provisions. Part V requires acknowledgment of the order and
dissemination of the order now and in the future to persons with
supervisory responsibilities and all employees, agents, and
representatives who participate in conducted relating to the subject
matter of the order. Part VI
[[Page 19764]]
ensures notification to the FTC of changes in corporate status and
mandates that Respondents submit an initial compliance report to the
FTC. Part VII requires Respondents to retain documents relating to its
compliance with the order for a five (5) year period. Part VIII
mandates that Respondents make available to the FTC information or
subsequent compliance reports, as requested. Part IX is a provision
``sunsetting'' the order after twenty (20) years, with certain
exceptions.
The purpose of this analysis is to aid public comment on the
proposed order. It is not intended to constitute an official
interpretation of the complaint or proposed order, or to modify in any
way the proposed order's terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2018-09545 Filed 5-3-18; 8:45 am]
BILLING CODE 6750-01-P